FEATURE:
New clinical trial with RRMS or progressive forms of MS.
This trial is evaluating a type of immune cell therapy called “chimeric antigen receptor (CAR) T cell therapy” CAR T cell therapy is being evaluated for use in many autoimmune conditions. It has been a promising option for several types of cancers and is FDA approved as a therapy for leukemia, lymphoma, and multiple myeloma.
Researchers believe that, when used to address relapsing or progressive MS, CAR T cell therapy may help the body destroy malfunctioning immune cells, potentially leading to MS improvement or remission.
https://www.acceleratedcure.org/january-2025-research-spotlight/
FEATURE:
New clinical trial with RRMS or progressive forms of MS.
This trial is evaluating a type of immune cell therapy called “chimeric antigen receptor (CAR) T cell therapy” CAR T cell therapy is being evaluated for use in many autoimmune conditions. It has been a promising option for several types of cancers and is FDA approved as a therapy for leukemia, lymphoma, and multiple myeloma.
Researchers believe that, when used to address relapsing or progressive MS, CAR T cell therapy may help the body destroy malfunctioning immune cells, potentially leading to MS improvement or remission.
https://www.acceleratedcure.org/january-2025-research-spotlight/
Welcome to the MS Invincibles Resource Site
